|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Total revenue, net | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Operating loss | |||||
| Other income (expense), net: | |||||
| Interest income | |||||
| Exchange related gain, net | |||||
| Interest expense | |||||
| Gain on change in fair value of derivatives | |||||
| Other expense ( income) | |||||
| Total other expense, net | |||||
| Net Loss | |||||
| Other comprehensive income | |||||
| Unrealized gain on marketable securities | |||||
| Total other comprehensive income | |||||
| Total comprehensive loss | |||||
| Basic net loss per common share | |||||
| Basic weighted-average shares outstanding | |||||
| Diluted net loss per common share | |||||
| Diluted weighted-average shares outstanding | |||||
Loading...